Abstract
In same-day radioembolization, 99mTc-MAA SPECT/CT, 90Y radioembolization, and post-treatment 90Y SPECT/CT procedures are conducted on the same-day, resulting in a dual-isotope environment of 90Y and 99mTc during post-treatment imaging. This study aimed to quantify the impact of 99mTc on 90Y bremsstrahlung-SPECT/CT image quality and to establish an optimised imaging protocol for both clinical practice, and with advanced reconstruction techniques. Utilising a NEMA IQ phantom, contrast recovery coefficients (CRCs) were measured to evaluate the 90Y image quality degradation caused by 99mTc. SPECT/CT scans of 90Y-only and 90Y with varying amounts of 99mTc were conducted using a standard protocol (90-120 keV energy window, high-energy collimator) and various dual-isotope protocols. The standard protocol resulted in a marked CRC reduction, with the largest sphere's CRC decreasing from 0.21 (90Y-only) to 0.05 when 99mTc activity was 5% of 90Y. For an optimised protocol (160-200 keV energy window, high-energy collimator) CRC values were 0.16 for 90Y-only and 0.15 for 90Y+99mTc. The highest CRC values were achieved with an advanced Monte Carlo-based reconstruction, showing 0.58 for 90Y-only and 0.46 for 90Y+99mTc. Image quality degradation was noted in dual-isotope settings even when using an optimised protocol. Advanced reconstruction techniques markedly improved post-treatment image quality.
Original language | English |
---|---|
Pages (from-to) | 7511-7522 |
Number of pages | 12 |
Journal | Current oncology (Toronto, Ont.) |
Volume | 31 |
Issue number | 12 |
DOIs | |
Publication status | Published - 26 Nov 2024 |
Keywords
- Embolization, Therapeutic/methods
- Humans
- Liver Neoplasms/radiotherapy
- Phantoms, Imaging
- Radiopharmaceuticals/therapeutic use
- Single Photon Emission Computed Tomography Computed Tomography/methods
- Technetium/therapeutic use
- Tomography, Emission-Computed, Single-Photon/methods
- Yttrium Radioisotopes/therapeutic use